Who owns Gamamabs Pharma?

Gamamabs Pharma is currently owned by Irdi Capital-Investissement, through IRDI Impulsion, since 2021.

When did Irdi Capital-Investissement acquire Gamamabs Pharma?

Irdi Capital-Investissement acquired Gamamabs Pharma in 2021 (active for 5 years).

Healthcare·

France·Active·5yr hold

Gamamabs Pharma is a healthcare company, headquartered in France.

Entry

2021

Hold

5yr

Status

Active

Est. EV

–

Investor

HQFrance

SectorHealthcare

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

1 portfolio peer in IRDI Impulsion

6 comparable healthcare deals from other GPs

Already a member? Sign in

Data refreshed weekly · Sourced from public filings